Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wolfe Research Downgrades Adient to Peer Perform

Wolfe Research analyst Rod Lache downgrades Adient (NYSE:ADNT) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Wolfe Research analyst Rod Lache downgrades Adient (NYSE:ADNT) from Outperform to Peer Perform.

Morgan Stanley Maintains Equal-Weight on FedEx, Lowers Price Target to $250

By Benzinga Newsdesk

Today, 5:12 AM

Morgan Stanley analyst Ravi Shanker maintains FedEx (NYSE:FDX) with a Equal-Weight and lowers the price target from $270 to $250.

FDX

Eaton To Supply Breaktor Circuit Protection Technology To A European-Based Vehicle Manufacturer For New EV Models

By Bill Haddad

Today, 5:12 AM

https://www.businesswire.com/news/home/20220420005070/en/

ETN

Analyst Ratings

Expert Ratings for Tenet Healthcare

By Benzinga Insights

Today, 5:12 AM

Tenet Healthcare (NYSE:THC) has observed the following analyst ratings within the last quarter:

THC

Entrada Therapeutics Q3 EPS $(0.80) Up From $(9.78) YoY

By Benzinga Newsdesk

Today, 5:12 AM

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.80) per share. This is a 91.82 percent increase over losses of $(9.78) per share from the same period last year.

TRDA

Wolfe Research Downgrades Adient to Peer Perform

Related Posts

Morgan Stanley Maintains Equal-Weight on FedEx, Lowers Price Target to $250

Eaton To Supply Breaktor Circuit Protection Technology To A European-Based Vehicle Manufacturer For New EV Models

Expert Ratings for Tenet Healthcare

Entrada Therapeutics Q3 EPS $(0.80) Up From $(9.78) YoY